A pilot clinical trial published in Nature Biotechnology demonstrated a wearable, electrochemical aptamer‑based patch that continuously measures drug concentrations from interstitial fluid in humans. The study establishes feasibility for real‑time therapeutic drug monitoring (TDM) for medicines with narrow therapeutic windows and suggests utility for individualized dosing and safety monitoring. The demonstration paves a translational path from biosensor concept to regulated diagnostic device in therapeutic management.